ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,393Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 61

$761K Total Retail Price of All Prescriptions

Rank: 1 out of 61

884 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 884 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

1% of this provider’s 884 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 11,185 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 829 770 1 8
AMLODIPINE BESYLATE 694 612 2 5
LISINOPRIL 528 482 3 2
LOSARTAN POTASSIUM 492 456 4 17
FUROSEMIDE 489 418 5 9
CRESTOR 434 402 6 14
CARVEDILOL 414 333 7 1
WARFARIN SODIUM 354 333 8 11
METOPROLOL SUCCINATE 342 333 9 6
METOPROLOL TARTRATE 328 296 10 4
NEXIUM 320 260 11 43
ATORVASTATIN CALCIUM 300 276 12 7
OMEPRAZOLE 287 254 13 37
PRADAXA 237 228 14 24
ATENOLOL 233 230 15 18
LOVAZA 198 179 16 41
DIOVAN 193 182 17 22
RANEXA 181 165 18 28
LABETALOL HCL 170 143 19 50
LOSARTAN-HYDROCHLOROTHIAZIDE 167 151 20 40
RANITIDINE HCL 164 161 21 56
CLOPIDOGREL 161 151 22 3
ZETIA 160 152 23 23
DIGOXIN 157 143 24 15
LEVOTHYROXINE SODIUM 144 125 25 45
METFORMIN HCL 144 137 25 49
PLAVIX 138 134 27 10
ZOLPIDEM TARTRATE 136 103 28 55
PANTOPRAZOLE SODIUM 133 111 29 25
TAMSULOSIN HCL 131 122 30 70
HYDROCHLOROTHIAZIDE 111 90 31 16
CLONIDINE HCL 101 95 32 42
SPIRONOLACTONE 94 85 33 32
ISOSORBIDE MONONITRATE ER 93 81 34 12
KLOR-CON M20 88 87 35 31
LANSOPRAZOLE 86 72 36 86
METFORMIN HCL ER 85 85 37 88
HYDRALAZINE HCL 82 71 38 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 73 39 38
NITROSTAT 79 75 40 20
NIASPAN 78 68 41 26
PRAVASTATIN SODIUM 72 72 42 13
GABAPENTIN 71 70 43 59
SERTRALINE HCL 65 59 44 95
LIPITOR 63 59 45 27
AMLODIPINE BESYLATE-BENAZEPRIL 63 53 45 81
JANTOVEN 60 48 47 58
BYSTOLIC 58 47 48 35
DEXILANT 57 47 49 69
LOVASTATIN 54 43 50 57
EFFIENT 50 49 51 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.